Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
* To evaluate the safety and tolerability of escalating single doses of CAT-1004 relative to placebo in healthy adult volunteers. * To evaluate the pharmacokinetics (PK) of escalating single doses of CAT-1004 in healthy adult volunteers. * To evaluate the effect of a high-fat meal on single doses of CAT-1004 in healthy adult volunteers.
Key facts
- Study ID
- NCT01440166
- Run by
- Catabasis Pharmaceuticals
- People needed
- 52
- Starts
- 2011-09-01
- Expected to finish
- 2012-01-01
- Last updated by the study team
- 2012-02-06
Who can join
Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Celerion Clinical Research Unit — Lincoln, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.